Breast Reduction Surgery in India and UAE | Complete Patient Guide

• Women aged 18 and above (skeletal maturity confirmed) with disproportionately large breasts causing documented functional symptoms (neck/back/shoulder pain, skin rashes, postural deformity, activity limitation)

• Patients with a minimum resection volume typically ≥ 500 g per breast (threshold used by most insurance and surgical panels)

• Body Mass Index (BMI) ideally ≤ 35 kg/m²; patients with BMI 35–40 may be considered after optimisation; BMI > 40 is a relative contraindication requiring prehabilitation

• Non-smokers, or patients who have ceased smoking ≥ 6 weeks preoperatively (smoking raises wound-healing complication risk by 3–5× in skin-flap surgery)

• Patients with stable weight (not planning significant further weight loss or pregnancy in the near term, as these events alter outcomes)

• Patients with BREAST-Q functional subscale scores indicating clinically significant impairment

Required Preoperative Diagnostics:

• Full-field digital mammography (FFDM) or breast ultrasound for women ≥ 35 years or with a first-degree family history of breast cancer

• MRI breast if inconclusive mammographic findings or BRCA carrier status

• Complete blood count (CBC), coagulation profile (PT/INR/aPTT), metabolic panel, HbA1c (for diabetic patients)

• Electrocardiogram (ECG) and anaesthesia fitness evaluation

• Thrombosis risk stratification using the Caprini Score (DVT prophylaxis planning)

• Photographic documentation and 3D surface imaging (Vectra® or similar) for surgical planning

Contraindications:

• Active or incompletely treated breast malignancy (biopsy-proven; coordinate with oncology)

• Uncontrolled diabetes mellitus (HbA1c > 8.0%) — significantly elevates wound breakdown risk

• Active collagen vascular disease (e.g., systemic sclerosis) impairing wound healing

• Coagulopathies not amenable to peri-operative management

• Unrealistic aesthetic expectations not addressable by reduction alone

• Patients planning imminent pregnancy (lactation may be affected; counsel and defer when appropriate)

Breast reduction surgery is not a single monolithic operation; the surgeon selects a technique based on breast volume, degree of ptosis (Regnault classification Grades I–III), desired final volume, NAC position, patient body habitus, and the critical need to preserve nipple-areola vascularity and sensory innervation.

1. Inferior Pedicle with Inverted-T (Wise Pattern) Technique — Gold Standard for Large Reductions The most widely performed approach globally, suitable for large to massive macromastia. The NAC is carried on a broad inferior dermoglandular pedicle supplied by the fourth intercostal perforator and the internal mammary artery branches. Resection volumes of 500 g to > 2,500 g per side are reliably achieved. The resultant scar pattern forms an anchor or inverted-T (periareolar + vertical + horizontal inframammary). Long-term outcome data spanning > 30 years confirm durable relief of functional symptoms in > 95% of patients.

2. Vertical (Short-Scar / Lejour / Hall-Findlay) Technique — Preferred for Moderate Macromastia The vertical technique eliminates the horizontal inframammary scar, leaving only a periareolar + vertical scar (lollipop pattern). The superomedial pedicle, popularised by Hall-Findlay, provides excellent NAC perfusion and superior long-term breast shape. Optimal for resection volumes of 300–800 g per breast. Associated with lower revision rates for scar-related complaints and superior patient satisfaction on BREAST-Q aesthetics subscale in randomised trials.

3. Superomedial Pedicle with Wise Pattern — Versatile Hybrid Combines the reliable perfusion of the superomedial pedicle with the skin-pattern versatility of the Wise pattern. Increasingly preferred by high-volume surgeons for moderate-to-large reductions requiring precise NAC repositioning > 10 cm.

4. Free Nipple Graft (FNG) Technique — For Severe Ptosis or Very Large Resections Indicated when the NAC must be relocated > 15–20 cm or when pedicle length would compromise perfusion (e.g., very large breasts, BMI > 35). The NAC is detached, resized, and grafted back as a full-thickness skin graft. Trade-off: complete loss of nipple sensation and lactation capacity. Reserved for carefully counselled patients where safety and resection volume are prioritised over function.

5. Liposuction-Assisted Reduction / Pure Liposuction Reduction For patients with predominantly fatty macromastia (confirmed by ultrasound/MRI showing > 60–70% adipose content) without significant ptosis. VASER® ultrasound-assisted liposuction or power-assisted liposuction (PAL) can reduce breast volume by 300–600 cc per side with minimal scarring. Not appropriate where significant skin excess and ptosis coexist. Increasingly combined with the above open techniques to sculpt lateral breast rolls.

6. Robotic and Endoscopic Assistance Emerging in tertiary centres in India and the UAE: endoscopic visualisation and robotic-arm assistance (da Vinci® platform in selected centres) are being evaluated to improve haemostasis and reduce intraoperative blood loss in complex reductions, though open techniques remain the primary standard of care for this procedure.

7. Simultaneous Procedures Mastoscopy (intraoperative endoscopic evaluation of breast ducts), concurrent axillary lymph node assessment, and incidental benign lesion excision can be performed at the same sitting. All resected tissue is sent for routine histopathological examination — this has resulted in incidental detection of occult carcinoma in 0.06–4% of cases across published series, reinforcing the oncological value of the procedure.

PRE-OPERATIVE PHASE (4–6 Weeks Before Surgery)

• GAF Healthcare facilitates remote video consultation with the chosen plastic surgeon; 3D imaging files and medical records are reviewed electronically.

• Completion of mandatory diagnostics: mammography/ultrasound, blood panel, ECG, anaesthesia clearance.

• Caprini DVT risk score calculated; high-risk patients commence low-molecular-weight heparin (LMWH) perioperatively.

• Cessation of NSAIDs, aspirin, vitamin E, and herbal supplements ≥ 2 weeks prior (bleed risk).

• Smoking cessation confirmed ≥ 6 weeks preoperatively.

• Travel and accommodation arrangements finalised by GAF Healthcare; medical e-visa (India) or entry visa (UAE) processed.

• Arrival in country 1–2 days before surgery for in-person consultation, surgical marking, and pre-anaesthesia workup.

DAY OF SURGERY

• Admission to hospital, pre-operative surgical marking performed by the surgeon in upright position — critical for symmetry.

• General anaesthesia administered; duration typically 2.5–4 hours depending on resection volume and technique.

• Tumescent infiltration (epinephrine-containing solution) minimises intraoperative blood loss.

• Resected tissue weighed and labelled bilaterally; sent for histopathology.

• Surgical drains (Jackson-Pratt) placed if resection > 500 g per side.

• Compression surgical bra applied in theatre.

HOSPITAL STAY (Days 1–2)

• Vital monitoring, pain management (multimodal analgesia: paracetamol + NSAIDs + TAP-block or intercostal nerve blocks reduce opioid requirement).

• DVT prophylaxis: LMWH injections and pneumatic compression stockings from Day 0.

• First drain check and wound inspection on Day 1.

• Mobilisation begins Day 1 (gentle ambulation).

• Discharge Day 2 with compression bra, drain care instructions, oral antibiotics (5–7 days), and analgesics.

EARLY RECOVERY (Weeks 1–3, In-Country)

• Drains removed at Day 5–7 when output < 30 ml/24 hours.

• First outpatient wound review at Day 7 (suture line inspection, dressing change).

• Histopathology results reviewed at Day 7–10 consultation.

• Activity restriction: no lifting > 2 kg, no overhead arm movements for 3 weeks.

• Compression bra worn 24 hours/day for minimum 6 weeks.

• Patients are cleared for international air travel (fit-to-fly) typically at 14–21 days post-surgery, subject to wound integrity and surgeon sign-off.

MID RECOVERY (Weeks 3–6)

• Return to light desk work at 2–3 weeks.

• Driving permitted at 3–4 weeks (when arm movement and reflexes unrestricted).

• Scar management initiated: silicone gel sheets or silicone-based creams applied to healed incisions from Week 3 onward; continue for 3–6 months.

LONG-TERM RECOVERY (Months 2–6)

• Return to full exercise, swimming, and aerobic activity at 6 weeks.

• Final breast shape and scar maturation assessed at 3 months and 6 months.

• BREAST-Q outcome scores documented at 6 months for audit.

• Annual breast screening (mammography or ultrasound) recommended — surgical scarring is documented for radiologist reference to avoid future misinterpretation.